Product Specifications - Oxycodone HCl ER - DAVA Pharmaceuticals, Inc.

DAVA Pharmaceuticals, Inc.

DAVA Pharmaceuticals, Inc.

DAVA Pharmaceuticals, Inc.

ON-LINE TRAINING FOR OPIOID RISK MANAGEMENT

Oxycodone Hydrochloride Tablets Extended-Release (C-II) AB Rated to OxyContin® C-II Tablets
NDC #68774-	Photo	Product Name (Size)	Product Description	Case Pack*	Storage	Pricing
161-01		Oxycodone Hydrochloride Extended-Release Tablets 10mg (100s)	Color: White Shape: film-coated round convex tablets Markings: plain on one side; G161 on the other side	24	Controlled Room Temperature	No Longer Available
162-01		Oxycodone Hydrochloride Extended-Release Tablets 20mg (100s)	Color: Orange Shape: film-coated round convex tablets Markings: plain on one side; G162 on the other side	24	Controlled Room Temperature	No Longer Available
163-01		Oxycodone Hydrochloride Extended-Release Tablets 40mg (100s)	Color: Purple Shape: film-coated round convex tablets Markings: plain on one side; G163 on the other side	24	Controlled Room Temperature	No Longer Available
164-01		Oxycodone Hydrochloride Extended-Release Tablets 80mg (100s)	Color: Beige Shape: film-coated round convex tablets Markings: plain on one side; G164 on the other side	24	Controlled Room Temperature	No Longer Available
* Please place orders in Case Pack quantities OxyContin is a registered trademark of Purdue Pharma Oxycodone Hydrochloride Extended-Release Full Prescribing Information

ON-LINE TRAINING FOR OPIOID RISK MANAGEMENT

By selecting the below links, you will be exiting the DAVA Pharmaceuticals, Inc. web site.

Physician Training

Pharmacist Training

Patient Information

Distributor Manual

Oxycodone Information Line:

(800) 934-6729

Educational materials provided by IMPAX Laboratories, Inc.

< Back to Products


© Copyright 2005 DAVA Pharmaceuticals, Inc. All rights reserved. Legal \| Privacy Policy